We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Avacta Group plc announces successful outcome of “Gene Delivery” collaboration with FIT Biotech

News   May 23, 2018

 
Avacta Group plc announces successful outcome of “Gene Delivery” collaboration with FIT Biotech

Alastair Smith, CEO, Avacta

 
 
Advertisement
 

RELATED ARTICLES

AI Predicts Which Immune Key Opens Which Lock

News

A new artificial intelligence method means researchers can now link immune cells to their targets and for example uncouple which white blood cells recognize SARS-CoV-2. The developed tool has broad applications in understanding the function of immune system in infections, autoimmune disorders and cancer.

READ MORE

Red Hair Linked to Higher Pain Tolerance

News

Studies suggest that the general pain tolerance of people with red hair may be higher and they also respond more effectively to opioid pain medications, requiring lower doses.

READ MORE

Large Clinical Trial To Test Polyclonal Antibody Therapeutic for COVID-19

News

A trial evaluating a new fully-human polyclonal antibody therapeutic targeted to SARS-CoV-2, called SAB-185, has begun enrolling non-hospitalized people with mild or moderate cases of COVID-19.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Drug Discovery Genomics Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE